Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …
identified autoimmune disorder that presents in both adults and children as CNS …
[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
Hope for patients with neuromyelitis optica spectrum disorders—from mechanisms to trials
SJ Pittock, A Zekeridou, BG Weinshenker - Nature Reviews Neurology, 2021 - nature.com
Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory CNS disease that
primarily manifests as relapsing episodes of severe optic neuritis and myelitis. Diagnosis of …
primarily manifests as relapsing episodes of severe optic neuritis and myelitis. Diagnosis of …
Interleukin-6 receptor blockade in treatment-refractory MOG-IgG–associated disease and neuromyelitis optica spectrum disorders
M Ringelstein, I Ayzenberg, G Lindenblatt… - Neurology …, 2021 - AAN Enterprises
Background and Objectives To evaluate the long-term safety and efficacy of tocilizumab
(TCZ), a humanized anti–interleukin-6 receptor antibody in myelin oligodendrocyte …
(TCZ), a humanized anti–interleukin-6 receptor antibody in myelin oligodendrocyte …
[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management
W Ambrosius, S Michalak, W Kozubski… - International journal of …, 2020 - mdpi.com
Myelin oligodendrocyte glycoprotein (MOG)-associated disease (MOGAD) is a rare,
antibody-mediated inflammatory demyelinating disorder of the central nervous system …
antibody-mediated inflammatory demyelinating disorder of the central nervous system …
Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody–associated disease
Importance Recent studies suggest that maintenance intravenous immunoglobulin (IVIG)
may be an effective treatment to prevent relapses in myelin oligodendrocyte glycoprotein …
may be an effective treatment to prevent relapses in myelin oligodendrocyte glycoprotein …
[HTML][HTML] EU paediatric MOG consortium consensus: Part 5–Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
AL Bruijstens, EM Wendel, C Lechner, F Bartels… - European Journal of …, 2020 - Elsevier
In recent years, the understanding about the different clinical phenotypes, diagnostic and
prognostic factors of myelin oligodendrocyte glycoprotein-antibody-associated disorders …
prognostic factors of myelin oligodendrocyte glycoprotein-antibody-associated disorders …
Myelin oligodendrocyte glycoprotein-immunoglobulin G in the CSF: clinical implication of testing and association with disability
YN Kwon, B Kim, JS Kim, H Mo, K Choi… - Neurology …, 2021 - AAN Enterprises
Background and Objective To investigate the clinical relevance of CSF myelin
oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) testing in a large multicenter …
oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) testing in a large multicenter …
OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic …
Background Optic neuritis (ON) is the most common manifestation of myelin oligodendrocyte
glycoprotein antibody associated disorder (MOGAD) and multiple sclerosis (MS). Acute ON …
glycoprotein antibody associated disorder (MOGAD) and multiple sclerosis (MS). Acute ON …
Myelitis and other autoimmune myelopathies
SL Chiriboga, EP Flanagan - CONTINUUM: Lifelong Learning in …, 2021 - journals.lww.com
PURPOSE OF REVIEW This article provides an update on the clinical diagnosis and
management of immune-mediated myelopathies, including the relevance of imaging …
management of immune-mediated myelopathies, including the relevance of imaging …